Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis

Commons RJ., Rajasekhar M., Edler P., Abreha T., Awab GR., Baird JK., Barber BE., Chu CS., Cui L., Daher A., Gonzalez-Ceron L., Grigg MJ., Hwang J., Karunajeewa H., Lacerda MVG., Ladeia-Andrade S., Lidia K., Llanos-Cuentas A., Longley RJ., Pereira DB., Pasaribu AP., Pukrittayakamee S., Rijal KR., Sutanto I., Taylor WRJ., Thanh PV., Thriemer K., Vieira JLF., Watson JA., Zuluaga-Idarraga LM., White NJ., Guerin PJ., Simpson JA., Price RN., Adhikari B., Anstey NM., Assefa A., Boyd SC., Chau NH., Day NPJ., Degaga TS., Dondorp AM., Erhart A., Ferreira MU., Ghimire P., Green JA., Koh GCKW., Mekuria AH., Mueller I., Naadim MN., Nelwan EJ., Nosten F., Price DJ., Sattabongkot J., Stepniewska K., von Seidlein L., William T., Woodrow CJ., Woyessa A.

DOI

10.1016/s1473-3099(23)00430-9

Type

Journal article

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

02/2024

Volume

24

Pages

172 - 183

Permalink Original publication